Photo: Researcher in lab with microscope

Our impact so far

Since 1956, you’ve helped us invest over £218 million (in today’s money) in MS research, supporting some fantastic breakthroughs.

From the development of new treatments, to investing in world-leading MS researchers, your support has had a significant impact and helped us move towards our vision of a world free from the effects of MS.

We’ve been here for people with MS for over 60 years. Here are some of the most significant milestones we’ve reached along the way…


We establish a research trust fund at King’s College and Royal Infirmary Newcastle, supporting new scientists.


We fund an electron microscope for MS research at the University of York. Today, researchers are using advanced microscopes to understand myelin repair in MS.


At Leeds General Infirmary, we fund our first bladder and MS research project. Read more about our symptom management research.


The first collection of genes are linked to MS.


We fund our first MRI research project at the Institute of Neurology, London. Read about how this led to breakthroughs in MS diagnosis.


The first disease modifying treatment (DMT), beta interferon, was licensed in Europe for relapsing MS. We now have 11 DMTs available for relapsing MS.


We set the Edinburgh Centre for MS Research with generous support from the Volant Trust. The centre is co-led by Professor Charles ffrench-Constant and Professor Siddharthan Chandran.


Botox is licensed as a safe and effective treatment for overactive bladder in MS. We funded early research into the benefits of Botox for people with MS.


First positive clinical trial results for progressive MS are published. Simvastatin shows potential to slow or stop disability progression.


Research reveals the long term benefits of early treatment.


Ocrelizumab becomes the first licensed treatment for some people with progressive MS after being shown to slow progression in ealr primary progressive MS.

What next?

Our aim is to stop MS. But we need to continue funding world-class research to help us get there.

There has never been a more crucial time for MS research in the UK. From breakthroughs in MS treatments, to figuring out what causes it — we’re getting close to stopping MS.

Little by little, step by step, your contributions can — and will — help us go all the way.

> Donate today and we can stop MS together